The influence of stage migration on the comparison of surgical outcomes between D2 gastrectomy and D3 gastrectomy (para-aortic lymph node dissection): a multi-institutional retrospective study

American Journal of Surgery

Volumn 196, Issue 3, 2008, Pages 358-363

  Kunisaki, Chikara ^a   Takahashi, Masazumi ^b   Fukushima, Tadao ^c   Nagahori, Yutaka ^c   Akiyama, Hirotoshi ^a   Makino, Hirochika ^a   Otsuka, Yuichi ^a   Ono, Hidetaka A ^a   Kosaka, Takashi ^a   Takagawa, Ryo ^a   Shimada, Hiroshi ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY   (Japan)

^c YOKOSUKA KYOSAI HOSPITAL   (Japan)

Author keywords

Gastrectomy; Gastric cancer; Para aortic lymph node dissection; Stage migration

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; GASTRECTOMY; HUMAN; LYMPH NODE METASTASIS; MIGRATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; SURGICAL MORTALITY; TUMOR VOLUME;

ADENOCARCINOMA; FEASIBILITY STUDIES; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 49349108820     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.07.031     Document Type: Article

References (21)

1. Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer 5 (2002) 1-5
2. Cuschieri A., Fayers P., Fielding J., et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. The Surgical Cooperative Group. Lancet 347 (1996) 995-999
3. Bonenkamp J.J., Songun I., Hermans J., et al. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345 (1995) 745-748
4. Isozaki H., Okajima K., Fujii K., et al. Effectiveness of paraaortic lymph node dissection for advanced gastric cancer. Hepatogastroenterology 46 (1999) 549-554
5. Baba M., Hokita S., Natsugoe S., et al. Paraaortic lymphadenectomy in patients with advanced gastric carcinoma of the upper-third of the stomach. Hepatogastroenterology 47 (2000) 893-896
6. Kunisaki C., Shimada H., Yamaoka H., et al. Indications for para-aortic lymph node dissection in gastric cancer patients with para-aortic lymph node involvement. Hepatogastroenterology 47 (2000) 586-589
7. Japanese Gastric Cancer Association. Japanese Classification of Gastric Cancer. 2nd English edition. Gastric Cancer 1 (1998) 8-24
8. Kunisaki C., Shimada H., Takahashi M., et al. Implication of extended lymph node dissection stratified for advanced gastric cancer. Anticancer Res 23 (2003) 4181-4186
9. Kunisaki C., Hirotoshi A., Masato N., et al. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: A multi-institutional study. Ann Surg Oncol 13 (2006) 659-667
10. Bunt A.M.G., Hermans J., Smit V.T., van de Velde C.J.H., Fleuren G.J., and Bruijn J.A. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 13 (1995) 19-25
11. In: Sobin L.H., and Wittekind C.H. (Eds). TNM: Classification of Malignant Tumours. 6th ed (2002), Wiley-Liss, New York
12. Sasako M., Mcculloch P., Kinoshita T., and Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82 (1995) 346-351
13. Siewert J.R., Bottcher K., Stein U., et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228 (1998) 449-461
14. Brennan M.F. Lymph node dissection for gastric cancer. N Engl J Med 340 (1999) 956-957
15. Kunisaki C., Shimada H., Yamaoka H., et al. Significance of para-aortic lymph node dissection in advanced gastric cancer. Hepatogastroenterology 46 (1999) 2635-2642
16. Saito H., Osaki T., Murakami D., et al. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg 192 (2006) 296-300
17. Feinstein A.R., Sosin D.M., and Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic technique as a source of misleading statistics for survival in cancer. N Engl J Med 312 (1985) 1604-1608
18. Yoshikawa T., Sasao M., Sano T., et al. Stage migration caused by D2 dissection with para-aortic lymphadenectomy for gastric cancer form the results of a prospective randomized controlled trial. Br J Surg 93 (2006) 1526-1529
19. Wu C.W., Hsiung C.A., Lo S.S., et al. Stage migration influences on stage-specific survival comparison between D1 and D3 gastric cancer surgeries. Eur J Surg Oncol 31 (2005) 153-157
20. Bonenkamp J.J., Songun I., Hermans J., et al. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345 (1995) 745-748
21. Cuschieri A., Fayers P., Fielding J., et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. The Surgical Cooperative Group. Lancet 347 (1996) 995-999